Metabolic Response to Pegylated Arginine Deiminase in Mesothelioma With Promoter Methylation of Argininosuccinate Synthetase

被引：50

作者：

Szlosarek, Peter W. ^{[1
]}

Phuong Luong ^{[2
]}

Phillips, Melissa M. ^{[1
]}

Baccarini, Marina ^{[2
]}

Ellis, Stephen ^{[2
]}

Szyszko, Teresa ^{[1
]}

Sheaff, Michael T. ^{[1
]}

Avril, Norbert ^{[1
]}

机构：

[1] St Bartholomews Hosp, Barts & London Sch Med, London, England

[2] Barts & London Queen Marys Sch Med & Dent, London, England

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 07期

关键词：

MALIGNANT PLEURAL MESOTHELIOMA; PHASE-III; CANCER; THERAPY; DEPRIVATION; EXPRESSION; CISPLATIN; MELANOMA;

D O I：

10.1200/JCO.2012.42.1784

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：E111 / E113

页数：3

共 14 条

[1] Pegylated arginine deiminase treatment of patients with metastatic melanoma: Results from phase I and II studies [J].

Ascierto, PA ;

Scala, S ;

Castello, G ;

Daponte, A ;

Simeone, E ;

Ottaiano, A ;

Beneduce, G ;

De Rosa, V ;

Izzo, F ;

Melucci, MT ;

Ensor, CM ;

Prestayko, AW ;

Holtsberg, FW ;

Bomalaski, JS ;

Clark, MA ;

Savaraj, N ;

Fenn, LG ;

Logan, TF .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) :7660-7668

[2] Short-term treatment-related symptoms and quality of life: Results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup Study [J].

Bottomley, A ;

Gaafa, R ;

Manegold, C ;

Burgers, S ;

Coens, C ;

Legrand, C ;

Vincent, M ;

Giaccone, G ;

Van Meerbeeck, J .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (09) :1435-1442

[3] Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer [J].

Delage, Barbara ;

Fennell, Dean A. ;

Nicholson, Linda ;

McNeish, Iain ;

Lemoine, Nicholas R. ;

Crook, Tim ;

Szlosarek, Peter W. .

INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (12) :2762-2772

[4] Advances in the systemic therapy of malignant pleural mesothelioma [J].

Fennell, Dean A. ;

Gaudino, Giovanni ;

O'Byrne, Kenneth J. ;

Mutti, Luciano ;

van Meerbeeck, Jan .

NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (03) :136-147

[5] Arginine deprivation as a targeted therapy for cancer [J].

Feun, L. ;

You, M. ;

Wu, C. J. ;

Kuo, M. T. ;

Wangpaichitr, M. ;

Spector, S. ;

Savaraj, N. .

CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (11) :1049-1057

[6] Phase II Study of Pegylated Arginine Deiminase for Nonresectable and Metastatic Hepatocellular Carcinoma [J].

Glazer, Evan S. ;

Piccirillo, Mauro ;

Albino, Vittorio ;

Di Giacomo, Raimondo ;

Palaia, Raffaele ;

Mastro, Angelo A. ;

Beneduce, Gerardo ;

Castello, Giuseppe ;

De Rosa, Vincenzo ;

Petrillo, Antonella ;

Ascierto, Paolo A. ;

Curley, Steven A. ;

Izzo, Francesco .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (13) :2220-2226

[7] Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: Results from phase I/II studies [J].

Izzo, F ;

Marra, P ;

Beneduce, G ;

Castello, G ;

Vallone, P ;

De Rosa, V ;

Cremona, F ;

Ensor, CM ;

Holtsberg, FW ;

Bomalaski, JS ;

Clark, MA ;

Ng, C ;

Curley, SA .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (10) :1815-1822

[8]

Ott PA, 2009, J CLIN ONCOL, V27, p15s

[9] Medical progress - Advances in malignant mesothelioma [J].

Robinson, BWS ;

Lake, RA .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (15) :1591-1603

[10] Novel Mechanistic Insights into Arginine Deiminase Pharmacology Suggest 18F-FDG Is Not Suitable to Evaluate Clinical Response in Melanoma [J].

Stelter, Lars ;

Evans, Michael J. ;

Jungbluth, Achim A. ;

Zanzonico, Pat ;

Ritter, Gerd ;

Ku, Thomas ;

Rosenfeld, Eric ;

Bomalaski, John S. ;

Old, Lloyd ;

Larson, Steven M. .

JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (02) :281-286

← 1 2 →